Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Construction in Progress (2023 - 2025)

Historic Construction in Progress for Core Scientific (CORZ) over the last 3 years, with Q3 2025 value amounting to $688.7 million.

  • Core Scientific's Construction in Progress rose 34761.66% to $688.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $688.7 million, marking a year-over-year increase of 34761.66%. This contributed to the annual value of $162.9 million for FY2024, which is 1144.75% down from last year.
  • Core Scientific's Construction in Progress amounted to $688.7 million in Q3 2025, which was up 34761.66% from $477.5 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Construction in Progress registered a high of $688.7 million during Q3 2025, and its lowest value of $153.9 million during Q3 2024.
  • Its 3-year average for Construction in Progress is $323.9 million, with a median of $230.3 million in 2023.
  • In the last 5 years, Core Scientific's Construction in Progress plummeted by 1144.75% in 2024 and then skyrocketed by 34761.66% in 2025.
  • Core Scientific's Construction in Progress (Quarter) stood at $183.9 million in 2023, then dropped by 11.45% to $162.9 million in 2024, then skyrocketed by 322.89% to $688.7 million in 2025.
  • Its Construction in Progress stands at $688.7 million for Q3 2025, versus $477.5 million for Q2 2025 and $276.8 million for Q1 2025.